4 terminated. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 4 |
| Phase 2 | 3 | Terminated 3 |
Follow Omacor: new trials by email Literature Review of Omacor trials Research Report on Omacor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy Aldoxorubicin HCl, ALT-803, ETBX-011 - Pancreatic Cancer | Phase 1 / Phase 2 | Terminated | ImmunityBio, Inc. | 4 | 2017-12-28 | 2024-05-22 |
| QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy ALT-803, ETBX-011, GI-4000 - Pancreatic Cancer | Phase 1 / Phase 2 | Terminated | ImmunityBio, Inc. | 6 | 2017-11-06 | 2024-12-12 |
| The Effects of Lovaza® in Acute Myocardial Infarction Lovaza®, The placebo contained 1 gram of corn oil in each capsule. - Myocardial Infarction | Phase 1 / Phase 2 | Terminated | University of Rochester | 4 | 2010-06-01 | 2017-11-06 |
| Study of Fish Oil to Reduce ALT Levels in Adolescents Omega-3-acid ethyl esters, Placebo - Non-alcoholic Fatty Liver Disease, Fatty Liver | Phase 1 | Terminated | Boston University | 3 | 2008-06-01 | 2016-01-29 |
Pancreatic Neoplasms (2) · Acute Coronary Syndrome (1) · Fatty Liver (1) · Myocardial Infarction (1) · Non-alcoholic Fatty Liver Disease (1) · Overweight (1)
ImmunityBio, Inc. (2) · Boston University (1) · University of Rochester (1)
United States (4)
Carine M Lenders, MD, MS, ScD (1) · Robert Block, MD, MPH (1)